Criticizing the FDA can't be helpful to GNBT's pat
Post# of 36536
(Total Views: 279)
Posted On: 02/06/2021 7:17:29 PM
Criticizing the FDA can't be helpful to GNBT's path to approval (at least in the US), no matter how accurate Joe's synopsis is. The current administration is spending A LOT of money and effort to get the mRNA vaccines in people's arms.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼